MIMS proves the value of modernizing medical communication

MIMS proves the value of modernizing medical communication

/ 08:00 AM September 17, 2022

MIMS—the country’s leading omni channel professional resource for physicians and healthcare providers—is making waves by bagging a series of awards for its medical communication, drug listings, and healthcare information services. 

In 2022 alone, the company received six awards, including Best Leading Medical Communications Agency and Best Trusted Drug & Disease Information Company at the Golden Globe Annual Awards for Business Excellence. President of MIMS Philippines, Richard M. Rivera, was also acknowledged as Chief Executive Officer of the Year by the Golden Globe Annual Awards. 

MIMS Philippines

Representatives from MIMS Philippines attend the 2022 Golden Globe Annual Awards for Business Excellence, including Richard M. Rivera, who was named CEO of the Year.

This year, MIMS was also recognized as the Star Brand Quality Healthcare Information Source at the Philippine Social Media Awards, the Premier Drug & Disease Information Provider at the Elite Business & Leadership Awards, and the Leading & Innovative Drug and Disease Information Center at the Best Choice Awards.

MIMS provides value for its clients through its drug listing services, which provide doctors and health workers access to valuable information on a wide variety of drugs; its marketing platforms include publications like HealthToday and MIMS Doctor as well as MIMS.com, which provides healthcare information and research updates; and its medical communications services, which provides clients with scientific writing, surveys, publications, graphic and video design, event management, and more to ensure they can communicate effectively with physicians and other essential stakeholders.

FEATURED STORIES

Like many businesses, the company had many of its regular projects disrupted by the COVID-19 pandemic. But true to its values of being progressive, engaging, and insightful, the company adapted by pivoting to the digital space by bringing its services online through webinars, virtual events, and digital communications. 

MIMS Philippines

Employees from MIMS Philippines onstage to receive the award for Star Brand Quality Healthcare Information Source at the 2022 Philippine Social Media Awards (PSMA) | Photo courtesy of PSMA

These values, along with MIMS’ steadfast leadership and the hard work and perseverance of its employees are what have allowed the company to endure the pandemic, and what will allow it to stay ready for future challenges and opportunities. 

The recognition of MIMS across different industries through these awards shows that the company has proven the value of modernizing medical communication in the Philippines and the rest of Asia-Pacific. But with its eyes always turned to the future, MIMS continues to provide top-quality services and innovate new ways to provide essential healthcare information and generate value for all its stakeholders.

ADVT.

Read more Business stories: 

Cebu’s concrete supplier commits to support govt’s ‘Build, Better, More’ program

BDO Network Bank, Inc. Notice of Special Stockholders’ Meeting

Portofino Alabang: A seamless blend of luxe lifestyle and modern comfort

Subscribe to our business newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: #COVID19, BrandRoom, Healthcare
For feedback, complaints, or inquiries, contact us.

Subscribe to our business news

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.



© Copyright 1997-2023 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.